home / stock / imle / imle quote
Last: | $0.0679 |
---|---|
Change Percent: | 19.12% |
Open: | $0.05 |
Close: | $0.0679 |
High: | $0.07 |
Low: | $0.05 |
Volume: | 35,942 |
Last Trade Date Time: | 06/05/2020 04:55:12 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0679 | $0.05 | $0.0679 | $0.07 | $0.05 | 35,942 | 06-05-2020 |
$0.057 | $0.088 | $0.057 | $0.088 | $0.057 | 18,000 | 06-04-2020 |
$0.08 | $0.07 | $0.08 | $0.08 | $0.068 | 106,000 | 06-03-2020 |
$0.059 | $0.059 | $0.059 | $0.059 | $0.059 | 2,000 | 06-02-2020 |
$0.059 | $0.05 | $0.059 | $0.069 | $0.0391 | 30,673 | 05-29-2020 |
$0.08 | $0.061 | $0.08 | $0.08 | $0.061 | 4,200 | 05-28-2020 |
$0.061 | $0.039 | $0.061 | $0.061 | $0.039 | 5,100 | 05-27-2020 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 1,000 | 05-20-2020 |
$0.06 | $0.06 | $0.06 | $0.06 | $0.06 | 31,000 | 05-19-2020 |
$0.06 | $0.069 | $0.06 | $0.069 | $0.06 | 2,100 | 05-18-2020 |
$0.0545 | $0.05225 | $0.0545 | $0.0545 | $0.0523 | 2,500 | 05-15-2020 |
$0.08 | $0.08 | $0.08 | $0.08 | $0.08 | 47,000 | 05-13-2020 |
$0.08 | $0.0605 | $0.08 | $0.08 | $0.0605 | 1,200 | 05-12-2020 |
$0.0605 | $0.07 | $0.0605 | $0.09 | $0.0605 | 40,693 | 05-11-2020 |
$0.065 | $0.0579 | $0.065 | $0.066 | $0.0579 | 229,304 | 05-08-2020 |
$0.055 | $0.058 | $0.055 | $0.058 | $0.055 | 110,000 | 05-07-2020 |
$0.055 | $0.055 | $0.055 | $0.055 | $0.055 | 20,000 | 05-06-2020 |
$0.0549 | $0.063 | $0.0549 | $0.063 | $0.0549 | 54,500 | 05-05-2020 |
$0.06 | $0.055 | $0.06 | $0.063 | $0.055 | 84,500 | 05-04-2020 |
$0.055 | $0.032 | $0.055 | $0.055 | $0.0316 | 29,250 | 05-01-2020 |
News, Short Squeeze, Breakout and More Instantly...
SANTA ANA, Calif. , Dec. 17, 2019 /PRNewswire/ -- TransBiotec, Inc. (OTC: IMLE), developers of a patented non-invasive alcohol sensing system, announced today that it has closed on $1.0 million in financing from the sale of its Series A-1 Preferred Stock to SOBRSafe LLC, a special ...
SANTA ANA, Calif. , Nov. 15, 2019 /PRNewswire/ -- TransBiotec, Inc. (IMLE-OTC) is pleased to announce the appointment of Kevin Moore to the position of Chief Executive Officer, the appointment of David J. Gandini to the position of Chief Revenue Officer and the election of Gary ...